TQA2226
/ Sino Biopharm, Ampsource Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 01, 2024
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
(clinicaltrials.gov)
- P1 | N=74 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
November 22, 2023
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
(clinicaltrials.gov)
- P1 | N=74 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1